Suppr超能文献

特发性肺纤维化合并肺气肿可延缓肺活量的下降。

Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.

机构信息

Department of Respiratory Medicine, Fukuoka University School of Medicine, 7-45-1, Nanakuma, Jonanku, Fukuoka 814-0180, Japan.

出版信息

Respir Med. 2009 Aug;103(8):1209-15. doi: 10.1016/j.rmed.2009.02.001. Epub 2009 Feb 28.

Abstract

Although previous authors have reported single data point, yearly changes in respiratory function have not been examined in combined pulmonary fibrosis and emphysema (CPFE). To quantify the annual changes in respiratory function of patients with CPFE and to examine the difference in survival between CPFE patients and patients with idiopathic pulmonary fibrosis without emphysema (IPF alone), 26 patients with CPFE and 33 IPF alone patients, whose respiratory function had been monitored for at least a year, were selected. The baseline of vital capacity percent predicted (VC% pred) in CPFE patients was greater than that in IPF-alone patients (86.6+/-24.0% vs. 72.8+/-19.4%, p=0.018). The annual decrease in VC% pred was significantly less in CPFE patients than in IPF-alone patients (-1.2+/-4.8% vs. -8.0+/-7.4%, p<0.001). Baseline ratio of forced expiratory volume in one second to forced vital capacity (FEV(1)/FVC%) in CPFE patients was lower than that in IPF-alone patients (76.6+/-8.5% vs. 85.2+/-6.7%, p<0.001). In the CPFE group, FEV(1)/FVC% tended to decrease with time (-0.5+/-2.2% per year), but, in contrast, it increased in IPF-alone patients (+1.1+/-3.4% per year) (p=0.036). Baseline of diffusing capacity percent predicted (DLco% pred) was significantly lower in CPFE patients than in IPF-alone patients (45.3+/-15.0% vs. 60.7+/-19.8%, p=0.003). The annual decrease in DLco% pred was lower in CPFE patients than in IPF-alone patients (-3.7+/-7.9% vs. -10.7+/-8.8%, p=0.042). There was no significant difference in the survival duration between 26 CPFE and 33 IPF-alone patients according to Kaplan-Meier analysis. Ventilatory and gas-exchange deterioration during the course of IPF became mild when emphysema was coexistent.

摘要

尽管先前的作者已经报告了单个数据点,但尚未检查合并性肺纤维化和肺气肿(CPFE)患者的呼吸功能的年度变化。为了量化 CPFE 患者呼吸功能的年度变化,并检查 CPFE 患者与无肺气肿的特发性肺纤维化(IPF 单独)患者之间的生存率差异,选择了 26 例 CPFE 患者和 33 例 IPF 单独患者,这些患者的呼吸功能至少监测了一年。CPFE 患者的肺活量预测百分比(VC%预)基线大于 IPF 单独患者(86.6+/-24.0%对 72.8+/-19.4%,p=0.018)。CPFE 患者的 VC%预年下降幅度明显小于 IPF 单独患者(-1.2+/-4.8%对-8.0+/-7.4%,p<0.001)。CPFE 患者的一秒用力呼气量与用力肺活量的比值(FEV(1)/FVC%)基线低于 IPF 单独患者(76.6+/-8.5%对 85.2+/-6.7%,p<0.001)。在 CPFE 组中,FEV(1)/FVC%随着时间的推移呈下降趋势(每年减少 0.5+/-2.2%),而在 IPF 单独患者中,FEV(1)/FVC%则呈上升趋势(每年增加 1.1+/-3.4%)(p=0.036)。CPFE 患者的弥散量预测百分比(DLco%预)基线明显低于 IPF 单独患者(45.3+/-15.0%对 60.7+/-19.8%,p=0.003)。CPFE 患者的 DLco%预年下降幅度低于 IPF 单独患者(-3.7+/-7.9%对-10.7+/-8.8%,p=0.042)。根据 Kaplan-Meier 分析,26 例 CPFE 患者和 33 例 IPF 单独患者的生存时间无显著差异。当肺气肿并存时,特发性肺纤维化过程中的通气和气体交换恶化变得轻微。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验